MedSynergies Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:MedSynergies Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12168
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MedSynergies Inc (MedSynergies), a subsidiary of Optum Inc, is a healthcare service provider that offers services in business aspects of medicine. The company offers revenue cycle management, consulting services, practice management, business process analysis and software integration solutions. Its solutions include MSIGHT, that helps healthcare providers to manage physician practices, assesses the operational, relational and financial health of the organizations and connects physicians, patients and optimizes operations. MedSynergies operates through hospitals, physician practices and other health networks across the US. The company has operations in Dallas, Lincoln, Omaha and Little Rock, the US. MedSynergies is headquartered in Irving, Texas, the US.

MedSynergies Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MedSynergies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MedSynergies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
MedSynergies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MedSynergies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
MedSynergies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
MedSynergies Inc, Medical Equipment, Deal Details 10
Venture Financing 10
MedSynergies Raises US$65 Million In Venture Financing 10
Partnerships 11
MedSynergies Forms Joint Venture with Sentara Healthcare 11
MedSynergies Forms Joint Venture with Catholic Health 12
MedSynergies Forms Joint Venture with Excellence Headquarters 13
MedSynergies Forms Joint Venture with Vanguard Health 14
Acquisition 15
Optum to Acquire MedSynergies, Healthcare IT Company 15
MedSynergies Inc – Key Competitors 16
MedSynergies Inc – Key Employees 17
MedSynergies Inc – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
MedSynergies Inc, Medical Equipment, Key Facts 2
MedSynergies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
MedSynergies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MedSynergies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
MedSynergies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MedSynergies Inc, Deals By Market, 2012 to YTD 2018 8
MedSynergies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
MedSynergies Raises US$65 Million In Venture Financing 10
MedSynergies Forms Joint Venture with Sentara Healthcare 11
MedSynergies Forms Joint Venture with Catholic Health 12
MedSynergies Forms Joint Venture with Excellence Headquarters 13
MedSynergies Forms Joint Venture with Vanguard Health 14
Optum to Acquire MedSynergies, Healthcare IT Company 15
MedSynergies Inc, Key Competitors 16
MedSynergies Inc, Key Employees 17

List of Figures
MedSynergies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
MedSynergies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
MedSynergies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
MedSynergies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
MedSynergies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MedSynergies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
MedSynergies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MedSynergies Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[MedSynergies Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Shell Oman Marketing Co (SOMS):企業の財務・戦略的SWOT分析
    Summary Shell Oman Marketing Co (Shell Oman), formerly Shell Marketing (Oman) Ltd, is an oil and gas company that markets fuel and lubricants. The company provides engine oils and grease for cars, motorcycles and trucks. It also markets Shell automotive, aviation and marine products. Shell Oman owns …
  • Dalian Wanda Group:企業の戦略・SWOT・財務情報
    Dalian Wanda Group - Strategy, SWOT and Corporate Finance Report Summary Dalian Wanda Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • QRxPharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary QRxPharma Ltd (QRxPharma) develops and commercializes treatments for pain management and abuse prevention products. The company’s product portfolio includes late and early stage clinical drug candidates. Its dual opioid product portfolio includes Moxduo IR (Q8003), an immediate release oral …
  • NSK Ltd (6471):企業の財務・戦略的SWOT分析
    NSK Ltd (6471) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Asahi Kasei Pharma Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Asahi Kasei Pharma Corp (Asahi Kasei Pharma), a subsidiary of Asahi Kasei Corp, discovers, develops, manufactures, and markets pharmaceuticals and diagnostic products. The company's portfolio encompasses prescription drugs, diagnostic reagents, and enzymes for diagnostic reagents. Its prescr …
  • Hexcel Corp (HXL):企業の財務・戦略的SWOT分析
    Hexcel Corp (HXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Bellicum Pharmaceuticals Inc (BLCM):製薬・医療:M&Aディール及び事業提携情報
    Summary Bellicum Pharmaceuticals, Inc. (Bellicum) is a clinical stage biopharmaceutical company, which is engaged in developing cellular immunotherapies for the treatment of cancer. The company develops its product candidates through its chemical induction of dimerization technology platforms in the …
  • G-III Apparel Group Ltd (GIII):企業の財務・戦略的SWOT分析
    Summary G-III Apparel Group, Ltd. (G-III or “the company”) is an apparel and footwear manufacturing company. The company designs, manufactures and markets outerwear, dresses, sportswear, swimwear, women's suits and performance wear, luggage, footwear, and women's handbags, leather goods, and cold we …
  • CeQur SA:医療機器:M&Aディール及び事業提携情報
    Summary CeQur SA (CeQur) is a medical device company that develops and commercializes insulin delivery systems. The company offers product PAQ, a wearable insulin delivery device, which delivers both basal and bolus doses. Its PAQ product consist two components such as insulin reservoir and messenge …
  • Nerviano Medical Sciences Srl:製薬・医療:M&Aディール及び事業提携情報
    Summary Nerviano Medical Sciences Srl (NMS) is a drug development company that discovers and develops novel anticancer drugs. The company's pipeline products include anticancer compounds such as Danusertib, Encorafenib, Entrectinib, ADC Payload programs, PARP1 program, NMS-088, Brostallicin, Milcicl …
  • Mitsubishi Tanabe Pharma Corp (4508):企業の財務・戦略的SWOT分析
    Mitsubishi Tanabe Pharma Corp (4508) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • SBI Holdings Inc (8473):企業の財務・戦略的SWOT分析
    SBI Holdings Inc (8473) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Pinnacle Entertainment Inc:戦略・SWOT・企業財務分析
    Pinnacle Entertainment Inc - Strategy, SWOT and Corporate Finance Report Summary Pinnacle Entertainment Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Citius Pharmaceuticals Inc (CTXR)-製薬・医療分野:企業M&A・提携分析
    Summary Citius Pharmaceuticals Inc (Citius), formerly Trail One Inc, is a specialty pharmaceutical company that focused on the development and commercialization of adjunctive cancer care and critical care drug products. The company‘s proprietary product candidates include mino-lok, an antibiotic loc …
  • H.B. Fuller Co (FUL):企業の財務・戦略的SWOT分析
    H.B. Fuller Co (FUL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Abzena Plc (ABZA):企業の財務・戦略的SWOT分析
    Summary Abzena Plc (Abzena), formerly Polytherics Group Ltd, is a life science company that provides complementary services and technologies to enable the selection, development and manufacture of biopharmaceuticals products based on antibodies and other proteins. The company's technologies include …
  • RHÖN-KLINIKUM AG:企業の戦略・SWOT・財務分析
    RHÖN-KLINIKUM AG - Strategy, SWOT and Corporate Finance Report Summary RHÖN-KLINIKUM AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Ricerca Biosciences LLC-製薬・医療分野:企業M&A・提携分析
    Summary Ricerca Biosciences LLC (Ricerca), formerly Ricerca Inc, a subsidiary of Main Market Partners LLC, is a contract research organization that offers services to accelerate drug development. The organization's service portfolio includes drug safety and metabolism, chemical development, agrochem …
  • Cleanaway Waste Management Ltd (CWY):企業の財務・戦略的SWOT分析
    Cleanaway Waste Management Ltd (CWY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Promedior Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Promedior Inc (Promedior) is a clinical-stage biotechnology company that develops medicines for the treatment of fibrotic disorders. The company’s pipeline products include PRM-151 and PRM-167. PRM-151 is used in the treatment of rare systemic fibrotic diseases such as myelofibrosis and idio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆